Ocaliva Approved for Rare Liver Disease - U.S. News & World Report

Bidness ETC

Ocaliva Approved for Rare Liver Disease U.S. News & World Report TUESDAY, May 31, 2016 (HealthDay News) -- Ocaliva (obeticholic acid) has been approved by the U.S. Food and Drug Administration to treat a rare chronic liver disease called primary biliary cholangitis (PBC). The disease causes the liver's small bile ... Intercept Pharma's new liver disease drug comes with hefty price tag: $70000 a yearMarketWatch FDA approves Ocaliva for rare, chronic liver diseaseFDA.gov New Primary Biliary Cholangitis Treatment ApprovedPharmacy Times Bidness ETC -Benzinga -P&T Community -CNA Finance (press release) all 19 news articles »

from Health - Google News http://news.google.com/news/url?sa=t&fd=R&ct2=us&usg=AFQjCNFlekb8zDsullfUI2iAS3ii5b1umw&clid=c3a7d30bb8a4878e06b80cf16b898331&cid=52779124142267&ei=zeFNV-i_F4mS3AGk76vIDg&url=http://health.usnews.com/health-care/articles/2016-05-31/ocaliva-approved-for-rare-liver-disease
via IFTTT